Synopsys Inc Form 4 Filings

SYNOPSYS INC (SNPS) reported that Janet Lee, GC & Corporate Secretary, exercised 2,283 Restricted Stock Units into an equal number of shares of common stock on September 11, 2026. In connection with this vesting, 993 shares of common stock were withheld by Synopsys to satisfy tax withholding obligations, at a price of $397.38 per share, as approved by the Compensation Committee. Following the derivative transaction, Lee continues to hold 4,565 Restricted Stock Units directly, and no Rule 10b5-1 trading plan is reported.

SYNOPSYS INC (SNPS) reported that officer Janet Lee, General Counsel & Corporate Secretary, exercised a restricted stock unit award on September 1, 2026. 699 restricted stock units converted into the same number of shares of common stock, while 304 shares were withheld by Synopsys to cover tax withholding obligations related to this vesting. Following the exercise, 1,398 restricted stock units remained outstanding for the reporting person. No Rule 10b5-1 trading plan is reported in connection with these transactions.

SYNOPSYS INC (SNPS) director and president & CEO Ghazi Sassine acquired 27 shares of common stock on August 31, 2026 through an acquisition classified as an “other” transaction under the company’s Employee Stock Purchase Plan at a reported price of $360.961 per share, bringing his direct holdings to 76,865 shares.

No transactions were reported under a Rule 10b5-1 trading plan, and no derivative securities were reported in this filing.

SYNOPSYS INC (SNPS) reported that Deputy CFO & CAO Sudhindra Kankanwadi acquired 27 shares of common stock on August 31, 2026 through participation in the Synopsys, Inc. Employee Stock Purchase Plan at a price of $360.961 per share. Following this transaction, the officer directly holds 22,717 shares of Synopsys common stock, and no Rule 10b5-1 trading plan is reported.

SYNOPSYS INC (SNPS) reported that Chief Revenue Officer Michael Ellow acquired 27 shares of common stock on August 31, 2026 through an acquisition of stock under the Synopsys, Inc. Employee Stock Purchase Plan at a price of $360.96 per share. After this transaction, he held 2,612 shares directly and 16 shares indirectly through a family trust. No Rule 10b5-1 trading plan is reported for these transactions.

SYNOPSYS INC (SNPS) reports that Executive Chair Aart de Geus exercised and sold company equity over August 31 and September 1, 2026. He exercised in total 49,641 non-qualified stock options at an exercise price of $135.88 per share to acquire the same number of common shares, then sold 25,000 shares at a weighted average price of $441.7646 and 24,641 shares at a weighted average price of $419.4401 in open-market transactions. He also acquired 22 shares through the Synopsys Employee Stock Purchase Plan. All reported transactions were effected under a Rule 10b5-1 trading plan adopted October 14, 2025. Indirect holdings after these transactions include 308,791 shares held by a Family Trust and 14,500 shares held by a Partnership.

For SYNOPSYS INC (SNPS), Executive Chair Aart de Geus reported an option exercise and related share sale. On 2026-08-28 he exercised 25,000 Non-Qualified Stock Options at an exercise price of $135.88 per share, acquiring an equal number of SNPS common shares. On the same date, he sold 25,000 common shares at a weighted average price of $445.5502 per share in multiple transactions. Following these transactions, he directly held 49,641 shares, and indirectly held 308,791 shares through a Family Trust and 14,500 shares through a Partnership. The filing states that these transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 14, 2025.

Synopsys Inc. executive Janet Lee, GC & Corporate Secretary, reported the vesting and settlement of 729 Restricted Stock Units into 729 shares of common stock on 2026-08-16. In connection with this vesting, 318 shares of common stock were retained by the company at $421.50 per share to satisfy Ms. Lee’s tax withholding obligations, as approved by the Compensation Committee. Following the transaction, Ms. Lee held 4,374 restricted stock units, with no remaining derivative positions reported in this filing.

Synopsys Inc. Chief Revenue Officer Michael Ellow reported routine equity compensation activity involving restricted stock units and related tax withholding. On 2026-06-15, 5,128 restricted stock units converted into an equal number of shares of common stock in two installments of 1,080 and 4,048 units.

To cover tax withholding obligations tied to this vesting, the company retained 2,543 shares at a price of $454.38 per share, as approved by the Compensation Committee. After these transactions, Ellow holds 2,041 shares of Synopsys common stock directly and 16 shares indirectly through a family trust, along with 26,713 remaining restricted stock units.

Synopsys Inc. general counsel and corporate secretary Janet Lee reported routine equity compensation activity involving restricted stock units. On 2026-06-15, 540 restricted stock units converted into 540 shares of common stock, reflecting a scheduled vesting.

On the same date, 235 common shares were withheld by Synopsys at a price of $454.38 per share to satisfy Ms. Lee’s tax withholding obligations, as approved by the Compensation Committee. After these transactions, she directly held 15,582 shares of common stock and 2,698 restricted stock units.

Synopsys deputy CFO and chief accounting officer Sudhindra Kankanwadi reported routine equity compensation activity involving restricted stock units. On June 15, 2026, 720 restricted stock units converted into 720 shares of Synopsys common stock as part of a scheduled vesting.

Of these shares, 249 were retained by Synopsys to cover the related tax withholding obligations, as approved by the Compensation Committee, leaving a net 471 shares effectively added to his directly held common stock. Following these transactions, he directly holds 22,690 shares of common stock and 3,597 restricted stock units.

Synopsys CFO Shelagh Glaser reported routine equity compensation activity involving restricted stock units. On June 15, 2026, 1,259 restricted stock units converted into the same number of shares of Synopsys common stock, reflecting a scheduled vesting event. In connection with this vesting, 436 shares of common stock were retained by Synopsys at a price of $454.38 per share to satisfy tax withholding obligations approved by the Compensation Committee, rather than being sold in the open market. Following these transactions, Glaser directly owned 1,452 shares of common stock and indirectly held 14,358 shares through a trust.

Synopsys Inc. director and president/CEO Ghazi Sassine exercised equity awards and sold shares in a pre-planned transaction. On 2026-06-15, he exercised options and restricted stock units to acquire a total of 17,913 shares of common stock, including 14,603 shares from non-qualified stock options at an exercise price of $135.88 per share and 3,310 shares from restricted stock units that convert one-for-one into common stock.

On the same date, he sold 14,603 shares of common stock in open-market transactions at a weighted average price of $458.962 per share under a Rule 10b5-1 trading plan adopted on September 19, 2025, and 1,492 shares were withheld by the company to cover tax obligations related to RSU vesting. Following these transactions, he holds 75,020 shares of Synopsys common stock directly.

Synopsys executive chair Aart de Geus reported routine equity compensation activity involving restricted stock units (RSUs). On 2026-06-15, 449 RSUs converted into the same number of common shares, reflecting a scheduled vesting event.

To cover related tax withholding obligations, 156 common shares were retained by the company at a price of $454.38 per share, as approved by the Compensation Committee. Following these transactions, de Geus directly owned 120,421 shares of Synopsys common stock and held 2,244 RSUs, plus additional indirect holdings through a partnership and a family trust.

Synopsys CFO Shelagh Glaser reported an open-market sale of 3,394 shares of Common Stock at a weighted average price of about $450.02 per share, executed through a trust. The transactions were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on January 13, 2026. After the sale, Glaser indirectly held 14,358 shares through the Karl and Shelagh Glaser Revocable Trust and directly held 629 shares. A footnote also describes a prior transfer of 17,752 shares into this revocable trust, noted as exempt under Rule 16a-13.

Synopsys Inc.'s General Counsel and Corporate Secretary, Janet Lee, reported routine equity compensation activity involving restricted stock units. She exercised 699 restricted stock units into the same number of common shares, while 304 common shares were retained by the company to satisfy tax withholding obligations approved by the Compensation Committee. After these transactions, she holds 15,277 shares of common stock directly and 2,097 restricted stock units, which each convert into one share of Synopsys common stock as they continue to vest over time.

Cohn Jesse reported acquisition or exercise transactions in this Form 4 filing.

Synopsys Inc. director Jesse Cohn reported two stock awards of common stock as part of his board compensation. He received 372 shares and 710 shares at a stated price of $0.0000 per share, reflecting non-cash equity grants rather than open-market purchases.

After these awards, one line in the filing shows Cohn directly holding 1,082 shares of common stock, and another shows 710 shares held directly. Footnotes explain that 372 shares vest in three equal installments before each of the first three Annual Meetings following the grant date, while 710 shares vest before the first Annual Meeting following the grant date, in each case subject to continued Board service.

Synopsys executive Janet Lee reported routine equity compensation activity involving restricted stock units and related tax withholding. On 2026-05-16, 729 restricted stock units converted into the same number of shares of Synopsys common stock at a stated price of $0.0000 per share, reflecting a non-cash derivative exercise.

To cover tax obligations from this vesting, 318 shares of common stock were disposed of at $502.42 per share through share withholding approved by the Compensation Committee, as described in the footnotes. The filing also shows 5,103 restricted stock units remaining after these transactions.

Vijayaraghavan Ravi K reported acquisition or exercise transactions in this Form 4 filing.

Synopsys Inc. director Vijayaraghavan Ravi K received an automatic stock award of 453 shares of common stock as a grant under the Amended and Restated Equity Incentive Plan. After this award, he directly holds 3,667 shares.

The shares subject to the award will vest on the date immediately preceding the first Annual Meeting following the grant date, provided he continues serving on the Board through that date.

Shimer Peter A reported acquisition or exercise transactions in this Form 4 filing.

Synopsys Inc. director Peter A. Shimer received a grant of 453 shares of common stock as an equity award. The shares were awarded at a stated price of $0.00 per share under an automatic grant from the company’s Amended and Restated Equity Incentive Plan.

These award shares will vest on the date immediately preceding the first Annual Meeting following the grant date, provided he continues Board service through that date. After this award, he directly holds a total of 1,378 shares of Synopsys common stock.

SCHWARZ JOHN reported acquisition or exercise transactions in this Form 4 filing.

Synopsys Inc. director John Schwarz received a grant of 453 shares of common stock as equity compensation. The award was granted at no cash cost per share and increased his directly held stake to 13,240 shares. According to the terms, the shares will vest on the date immediately preceding the first Annual Meeting following the grant date, as long as he continues to serve on the board until that time. The grant was made as an automatic award under Synopsys’ Amended and Restated Equity Incentive Plan.

Sargent Jeannine P reported acquisition or exercise transactions in this Form 4 filing.

SYNOPSYS INC director Jeannine P. Sargent received a stock award of 453 shares of Common Stock as board compensation. The award was granted at no cash cost on April 16, 2026 and will vest on the date immediately preceding the first Annual Meeting following the grant, if she continues serving on the board.

After this grant, she holds 2,997 shares directly. A separate line in the filing shows an additional 445 shares held indirectly by a Family Trust. The filing reflects routine equity compensation rather than an open-market stock purchase or sale.

PAINTER ROBERT G reported acquisition or exercise transactions in this Form 4 filing.

SYNOPSYS INC director Robert G. Painter received an equity award of 453 shares of Common Stock as compensation. The shares were granted at a price of $0.00 per share and are scheduled to vest on the date immediately preceding the first Annual Meeting following the grant, contingent on his continued Board service. Following this award, he directly holds 2,744 shares of Synopsys common stock.

JOHNSON MERCEDES reported acquisition or exercise transactions in this Form 4 filing.

Synopsys director Mercedes Johnson reported receiving an automatic award of 453 shares of common stock, granted at no cost under the company’s Amended and Restated Equity Incentive Plan. These shares will vest on the date immediately preceding the first Annual Meeting following the grant date, assuming continued Board service.

Johnson also reported an internal transfer of 491 previously directly held shares into the Mercedes Johnson Trust, bringing her indirectly held position through the trust to 2,390 shares. This transfer is disclosed as exempt from Section 16 under Rule 16a-13.

CHIZEN BRUCE R reported acquisition or exercise transactions in this Form 4 filing.

Synopsys Inc. director Bruce R. Chizen received an automatic equity award of 453 shares of Common Stock of Synopsys Inc. The shares were granted at a stated price of $0.0000 per share as a compensation award, not an open‑market purchase.

According to the award terms, the shares will vest on the date immediately preceding the first Annual Meeting following the grant date, provided he continues serving on the Board through that date. Following this grant, Chizen directly holds 16,162 shares of Synopsys common stock.

CHAFFIN JANICE reported acquisition or exercise transactions in this Form 4 filing.

Synopsys Inc. director Janice Chaffin received a stock award of 453 shares of common stock. The grant was made at a price of $0.00 per share as a compensation award rather than a market purchase. After this award, she directly holds 15,622 Synopsys shares.

The footnotes explain that the shares subject to this award will vest on the date immediately preceding the first Annual Meeting following the grant date, provided she continues to serve on the Board through that time. The award was granted automatically under Synopsys’ Amended and Restated Equity Incentive Plan.

Synopsys Inc. Chief Accounting Officer Sudhindra Kankanwadi exercised 793 restricted stock units into an equal number of common shares on March 15, 2026. To cover tax withholding tied to this vesting, 288 common shares were retained by Synopsys at $412.63 per share, as approved by the Compensation Committee. After these routine compensation-related transactions, Kankanwadi directly holds 22,219 shares of Synopsys common stock.

SYNOPSYS INC CFO Shelagh Glaser reported routine equity compensation activity. On March 15, 2026, 793 restricted stock units converted into 793 shares of common stock as an equity award vested. Following this vesting and related entries, she directly held 18,381 shares of Synopsys common stock.

To cover tax withholding obligations from the vesting, 282 shares were retained by the company at a value of $412.63 per share, as approved by the Compensation Committee and limited to the tax liability. This withholding is recorded as a disposition but is not an open-market sale.

Synopsys Inc. president and CEO Ghazi Sassine reported routine equity compensation activity. On March 15, 2026, he exercised 1,322 restricted stock units, each converting into one share of Synopsys common stock.

To cover tax withholding obligations tied to this vesting, 458 shares of common stock were retained by the company at a price of $412.63 per share, with the amount approved by the Compensation Committee and not exceeding the tax liability. Following these transactions, Sassine directly owned 75,020 shares of Synopsys common stock. No remaining derivative equity awards are shown in this filing.

Synopsys executive chair Aart de Geus reported routine equity compensation activity. He exercised 1,763 restricted stock units, which converted into the same number of Synopsys common shares. To cover tax withholding on this vesting, the company retained 630 shares at a price of $412.63 per share, as approved by the Compensation Committee.

After these transactions, de Geus directly holds 120,128 Synopsys shares. He also has indirect ownership of 308,791 shares through a family trust and 14,500 shares through a partnership. The tax-related share retention does not represent an open-market sale.

Synopsys Inc. executive Janet Lee reported equity award activity involving restricted stock units and common shares. On March 3, 2026, 292 restricted stock units were exercised, converting into 292 shares of common stock at a stated price of $0.00 per share.

On the same date, 127 shares of common stock were disposed of at $424.32 per share to cover tax withholding obligations tied to the vesting of the restricted stock unit installment. The company retained these shares, and the compensation committee approved the transaction, with the retained amount not exceeding the related tax liability. After these transactions, Lee directly held 14,471 shares of Synopsys common stock.

Shimer Peter A reported acquisition or exercise transactions in this Form 4 filing.

Synopsys director Peter A. Shimer received equity awards of Synopsys common stock. On February 27, 2026, he was granted 845 shares and a separate grant of 80 shares, both at a stated price of $0.00 per share, reflecting non-cash stock awards.

The 845-share award vests in three equal installments on the dates immediately preceding each of the first three annual stockholder meetings after the grant date, if he continues to serve on the board. The 80-share award vests in full on the date immediately preceding the first annual meeting after the grant date, also requiring continued board service. Both grants are automatic awards under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan.

Synopsys Inc. executive Janet Lee reported routine equity compensation activity involving restricted stock units and common shares. On 2026-03-01, 699 restricted stock units were exercised or converted, resulting in 699 shares of common stock, with no cash exercise price. After this, Lee held 2,796 restricted stock units and 14,610 common shares directly.

On the same date, 304 common shares were disposed of at $414 per share to satisfy tax withholding obligations related to the RSU vesting. According to the disclosure, these shares were retained by the company for tax withholding, the Compensation Committee approved the disposition, and the number of shares used was not more than the related tax liability. Following this tax-withholding transaction, Lee directly held 14,306 common shares.

Synopsys Inc executive chair Aart de Geus reported an acquisition of 28 shares of Synopsys common stock under the Synopsys, Inc. Employee Stock Purchase Plan. The transaction used code "J" for other acquisition or disposition at a price of $351.90 per share, bringing his directly held shares to 118,995.

He also reported indirect ownership of 308,791 shares held by a family trust and 14,500 shares held by a partnership, reflecting additional interests associated with him beyond his direct holdings.

SYNOPSYS INC CFO Shelagh Glaser acquired additional company stock through an employee program. On February 27, 2026, she obtained 28 shares of Synopsys common stock at $351.90 per share under the Synopsys, Inc. Employee Stock Purchase Plan. Following this transaction, her direct holdings totaled 17,870 shares of common stock.

Synopsys, Inc. director and president/CEO Ghazi Sassine reported an acquisition of company stock through an employee program. On February 27, 2026, he obtained 28 shares of Synopsys common stock at $351.90 per share under the Synopsys, Inc. Employee Stock Purchase Plan. Following this transaction, his directly held common stock position increased to 74,156 shares.

SYNOPSYS INC Chief Accounting Officer Sudhindra Kankanwadi reported an acquisition of company stock through an employee plan. On 2026-02-27, Kankanwadi acquired 28.0000 shares of common stock at a price of $351.9000 per share under the Synopsys, Inc Employee Stock Purchase Plan. Following this transaction, direct holdings increased to 21714.0000 shares of Synopsys common stock.

Synopsys Inc. officer Janet Lee, GC & Corporate Secretary, reported equity award transactions on February 16, 2026. She exercised 2,873 restricted stock units into common stock at an exercise price of $0.0, increasing her direct holdings to 14,832 common shares and 5,832 RSUs.

To cover related tax obligations on the vesting, the company retained 921 common shares at a price of $437.09 per share as a tax-withholding disposition, leaving Lee with 13,911 directly owned common shares after the transaction.

Synopsys, Inc. reported an insider stock sale by its General Counsel and Corporate Secretary, Janet Lee. On 01/12/2026, she sold 250 shares of Synopsys common stock in an open market transaction coded "S" at a price of $530 per share. Following this sale, she directly holds 11,959 shares of Synopsys common stock. The filing lists her as an officer and shows no derivative securities transactions in this report.

Synopsys Inc.’s General Counsel and Corporate Secretary, Janet Lee, reported a small insider sale of company stock. On 01/07/2026, she sold 250 shares of Common Stock at a price of $510 per share, according to a Form 4 insider trading report.

After this transaction, Lee directly beneficially owns 12,209 Synopsys shares. The filing shows only this single, non-derivative stock sale and no derivative securities transactions.

Synopsys Inc. reported an equity award for its Chief Financial Officer, Shelagh Glaser. The Compensation Committee granted her 7,554 restricted stock units under the Synopsys, Inc. 2006 Employee Equity Incentive Plan. These units have a conversion price of $0.0 and represent potential shares of common stock.

One-sixth of the units vest on 12/16/2025, with the remaining units vesting in five equal semi-annual installments through 12/15/2028, contingent on continued service. Following the grant, she holds 7,554 derivative securities directly.

Synopsys, Inc. reported an equity award for its Chief Accounting Officer, Sudhindra Kankanwadi. On 12/16/2025, he received a grant of 4,317 restricted stock units (RSUs) under the Synopsys, Inc. 2006 Employee Equity Incentive Plan. Each RSU represents a right to receive one share of Synopsys common stock for no cash exercise price.

According to the vesting schedule, one-sixth of the units vest on 06/15/2026, with the remaining units vesting in five equal semi-annual installments through 12/15/2028, as long as he continues to provide service to the company through each vesting date. This filing reflects a routine compensation-related grant rather than a market sale or purchase of shares.

Synopsys Inc reported an equity award to its Executive Chair and director, Aart de Geus. On 12/16/2025, he received 2,693 restricted stock units classified as derivative securities with an exercise price of $0.0, beneficially owned directly.

The grant was approved by the Compensation Committee under the Synopsys, Inc. 2006 Employee Equity Incentive Plan. One-sixth of the units vest on 06/15/2026, followed by five equal semi-annual installments, conditioned on continued service through each vesting date. The RSUs are scheduled to expire on 12/15/2028.

Synopsys, Inc. reported an equity award to one of its senior executives. On 12/16/2025, officer Janet Lee, who serves as GC & Corporate Secretary, received a grant of 3,238 restricted stock units under the Synopsys, Inc. 2006 Employee Equity Incentive Plan. Each unit represents a right to receive one share of Synopsys common stock for no cash exercise price.

According to the vesting terms, one-sixth of the units vest on 06/15/2026, with the remaining units vesting in five equal semi-annual installments through 12/15/2028, subject to continued service. The award is reported as directly owned and is a routine part of executive equity compensation, not an open-market stock sale or purchase.

Synopsys, Inc. reported that Chief Revenue Officer Michael Ellow received a grant of 24,286 restricted stock units on December 12, 2025. Each unit represents the right to receive one share of Synopsys common stock for no cash payment.

The grant was approved by the Compensation Committee under the Synopsys, Inc. 2006 Employee Equity Incentive Plan. One-sixth of the units vest on June 15, 2026, with the remaining units vesting in five equal semi-annual installments through December 15, 2028, subject to Mr. Ellow’s continued service.